FlowCardia
VerifiedFlowCardia designs and develops catheter-based technologies for the treatment of totally occluded coronary and peripheral arteries.
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$80m (Public information from May 2010)
Sunnyvale California (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
| investor | $0.0 | round | |
$80.0m Valuation: $80.0m | Acquisition | ||
| Total Funding | 000k | ||